Arthritis Center of Reno

Reno, Nevada 89502

0 studies enrolling now · 17 studies all time

What they study most

Ankylosing Spondylitis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Gout, Osteoarthritis, Rheumatoid Arthritis

Studies at this site

• Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis — Completed
• Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee — Completed
• Trial With HuMax-CD4 in Participants With Rheumatoid Arthritis (RA) Failing Treatment With Methotrexate (MTX) and a TNF-alpha Blocker — Stopped early
• Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate — Completed
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2) — Completed
• A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab — Stopped early
• A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis — Completed
• A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients — Status unconfirmed
• Abatacept Versus Adalimumab Head-to-Head — Completed
• MPC-004 for the Treatment of an Acute Gout Flare — Completed
• Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout — Completed
• Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects — Completed
• A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis — Completed
• Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) — Completed
• A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis — Completed